Richard Rohrer
About
In The Last Decade
Richard Rohrer
10 papers receiving 407 citations
Peers
Comparison fields: 5 of 40
- Epidemiology 348
- Infectious Diseases 110
- Oncology 89
- Transplantation 66
- Surgery 59
Countries citing papers authored by Richard Rohrer
This map shows the geographic impact of Richard Rohrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Rohrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Rohrer more than expected).
Fields of papers citing papers by Richard Rohrer
This network shows the impact of papers produced by Richard Rohrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Rohrer. The network helps show where Richard Rohrer may publish in the future.
Co-authorship network of co-authors of Richard Rohrer
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Rohrer. A scholar is included among the top collaborators of Richard Rohrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Rohrer. Richard Rohrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 53 | |
| 2 | 5 | |
| 3 | 4 | |
| 4 | 65 | |
| 5 | 39 | |
| 6 | 61 | |
| 7 | A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group. | 11 |
| 8 | 160 | |
| 9 | Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group. | 13 |
| 10 | [Demonstration of the differential expression of IGF-II in various embryonal kidney tumors using slot-blot hybridization and in-situ hybridization]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.